Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Maria C Freire is Director at Exelixis. OQRO lists 7 transactions filed with the SEC under this name, the latest on Jun 11, 2026, each linked to the official Form 4.
Director
Disclosures on record
7
Companies involved
3
BiogenBIIB
Jun 9, 20262,005disclosed Jun 11
DetailsOfficial recordExelixisEXEL
5 disclosures · Feb 2025 – May 2026 · 2 sold
As of the latest filing on , Maria C Freire reported holding 109,186 shares of Exelixis (EXEL), worth about $7.46M at the last close of $68 (Nov 18, 2026). Holdings are also on file at Biogen (BIIB), Alexandria Real Estate Equities (ARE); together they are worth about $10.1M. In the last 12 months, Maria C Freire sold $949K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Exelixis EXEL | 109,186 | 109K direct | $68 | $7.46M | May 27, 2026 |
| Biogen BIIB | 8,820 | 8,820 direct | $251 | $2.22M | Jun 9, 2026 |
| Alexandria Real Estate Equities ARE | 10,946 | 11K direct | $42 | $464K | Jan 15, 2026 |
Is this Maria C Freire’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
May 27, 20268,367disclosed May 29
May 7, 2026Sold~$949Kdisclosed May 8
DetailsOfficial recordMay 7, 202621Kdisclosed May 8
DetailsOfficial recordMay 7, 202621Kdisclosed May 8
DetailsOfficial recordFeb 14, 2025Sold~$1.54Mdisclosed Feb 20
DetailsOfficial recordAlexandria Real Estate EquitiesARE
Jan 15, 20263,493disclosed Jan 20
DetailsOfficial recordMaria C Freire has no open-market purchase on record since 2017 across 2 companies. Sales in each of the last 3 years.
Maria C Freire reported 0 open-market purchases and 9 sales since 2017; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $949K1×1 trade |
| 2025 | — | $1.54M1×1 trade |
| 2024 | — | $219K1×1 trade |
| 2022 | — | $424K2×2 trades |
| 2021 | — | $207K1×1 trade |
| 2020 | — | $255K1×1 trade |
| 2018 | — | $386K1×1 trade |
| 2017 | — | $246K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated May 27, 2026, Maria C Freire reported holding 109,186 shares of Exelixis (EXEL). At the last close of $68 on Nov 18, 2026, that is about $7.46M. This is the stake disclosed in filings, not a net worth.
No public filing gives Maria C Freire's net worth. What SEC Form 4 shows is the stock stake: 109,186 shares of Exelixis (EXEL), about $7.46M at the last close, plus holdings in 2 other companies, about $10.1M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Maria C Freire reported 1 open-market sale worth $949K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Maria C Freire has no open-market purchase on record since 2017 across 2 companies. Sales in each of the last 3 years.
In SEC filings since 2017: no open-market purchase is on record; the latest open-market sale is from 2026.
2 companies: Exelixis (EXEL, 2021–2026), Alexandria Real Estate Equities (ARE, 2017–2022).
Maria C Freire reported 0 open-market purchases and 5 sales here, 2017 to 2022.
Maria C Freire reported 0 open-market purchases and 4 sales here, 2021 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.